Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to take the guesswork out of treating Kids' pain

NCT ID NCT04833465

Recruiting now Knowledge-focused Sponsor: Children's National Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This observational study is working to create a more objective way to measure pain in children with juvenile idiopathic arthritis, lupus, or fibromyalgia. Researchers will follow 90 participants for one year, collecting data during regular clinic visits. The goal is to develop a 'nociceptive index' that could help doctors tailor treatments more precisely, reducing the trial-and-error approach currently used.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could lead to a more objective way to measure pain in children with rheumatologic diseases, helping doctors choose treatments more effectively.
What could go wrong
This is an early observational study with only 90 participants, so results may not apply to all patients. It is designed to gather pilot data, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fibromyalgia juvenile idiopathic arthritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FIBROMYALGIA JUVENILE IDIOPATHIC ARTHRITIS SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Locations

  • Children's National Health System

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.